Ronald P. Pelletier, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Ronald P. Pelletier, MD

Ronald P. Pelletier, MD Best Doctors 2011-2012

Nephrology
Surgeon Team

Contact Information

395 W 12th Ave
1st Fl
Columbus, OH 43210 [ map ]
PH: (614) 293-8545
FX: (614) 293-4541

Biography

Ronald P. Pelletier, MD, is a member of the Department of Pediatric Surgery at Nationwide Children’s Hospital and an Associate Professor of Surgery at The Ohio State University College of Medicine. His interests include kidney, pancreas and liver transplantation, and laparoscopic living donor nephrectomy. His research interests include the complications of renal transplantation and the mechanisms acute cellular and humoral rejection as well as the relationship between cellular and humoral alloimmunity.

Gender:

  • Male

Languages Spoken:

  • English

Research Interests

Research Funding*:

  • Prospective randomized single center comparative trial of long-term steroid free maintenance immunosuppression following steroid withdrawal comparing prednisonefree protocols of C2 dosed Neoral (Cyclosporine) and Myfortic (Mycophenolic Acid) vs Rapamune (with ML Henry and A Rajab), Novartis Pharmaceuticals
  • Study of FTY720A combined with corticosteroids and full or reduceddose Neoral® in de novo adult renal transplant recipients, Novartis Pharmaceuticals
  • Rapid four-day steroid withdrawal with thymoglobulin induction and maintenance immunosuppression with sirolimus and mycophenolate in primary cadaveric renal transplantation (with A Rajab and ML Henry), Wyeth Pharmaceuticals
  • Acute Humeral Rejection of Renal Allografts, NIH/NIAID
  • Rapid four-day steroid withdrawal with thymoglobulin induction and maintenance immunosuppression with sirolimus and mycophenolate in primary renal transplantation (with A Rajab and ML Henry), Wyeth Pharmaceuticals
  • Rapid four-day steroid withdrawal with thymoglobulin induction and maintenance immunosuppression with rapamycin and cyclosporine in primary cadaveric renal transplantation (with A Rajab), Wyeth Pharmaceuticals

Education and Training

Medical School

  • University of Cincinnati
    Date Completed: 06/30/1987

Internship

  • Ohio State University Wexner Medical Center
    Date Completed: 06/30/1988

Residency

  • Ohio State University Wexner Medical Center
    Date Completed: 06/30/1989

Residency

  • Ohio State University Wexner Medical Center
    Date Completed: 06/30/1991

Residency

  • Ohio State University Wexner Medical Center
    Date Completed: 06/30/1994

Fellowship

  • Ohio State University Wexner Medical Center
    Date Completed: 06/30/1996

Department:

  • Pediatric Surgery

Section:

  • General Pediatric Surgery

Specialty:

  • Surgery

Date of Appointment at Nationwide Children’s Hospital:

  • 11/18/1997

Publications

  • Pelletier RP, Henry ML. 2014. Program Specific Reports: Friend or Foe? —The Intended and Unintended Consequences of Scientific Registry of Transplant Recipient Program Specific Reports.  Current Transplantation Reports. Vol. 1, no. 2. (June): 86-90.
  • Pelletier RP, Phillips GS, Rajab A, Pesavento TE, Henry ML. 2014. Effects of Cardiovascular Comorbidity Adjustment on SRTR Risk-Adjusted Cox Proportional Hazard Models of Graft Survival.  Am J Transplantation. Vol. 97, no. 6. (March): 686-693.
  • Orandi BJ, Massie AB, Montogomery JR, Stegall MD, Dunn TB, Pelletier RP, Singh P, El-Amm JM, Lipkowitz GS, Sankari BR, Wellen J, Montgomery RA. 2014. Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study.  Am J Transplantation. Vol. 14, no. 7. (March): 1573-1580.
  • Gaughan A, Wang J, Pelletier RP, Nadasdy T, Brodsky S, Roy S, Lodder M, Bobek D, Mofatt-Bruce S, Fairchild RL, Henry ML, Hadley GA. 2014. Key Role for CD4 T Cells During Mixed Antibody-Mediated Rejection of Renal Allografts.  Am J Transplantation. Vol. 14, no. 2. (February): 284-294.
  • Von Visger J, Pesavento TE, Pelletier RP, Diez A, Nori U. 2013. Tolerance of ACE-Inhibitor/ARB use Post Renal Transplant. In 13th American Transplant Congress (ATC)
  • Pelletier RP, Von Visger J, Adams P, Henry ML. 2013. The Outcome of Luminex Single Antigen Bead DSA Detection in Post-Transplant Alloantibody Producing Recipients Does Not Correlate with Differential Graft Loss. In 13th American Transplant Congress (ATC)
  • Pelletier RP, Henry ML. 2013. KDRI Accurately Predicts Early Post-Transplant Kidney Function and Survival, as well as Late Survival. In 13th American Transplant Congress (ATC)
  • Pelletier RP, Rajab A, Pesavento TE, Henry ML. 2013. Pre-Transplant Cardiovascular Risk Factors Improve the SRTR Cox Proportional Hazard Model for 1 Year Patient Survival after Deceased Donor Kidney Transplant. In 13th American Transplant Congress (ATC)
  • Singh N, Parikh S, Bhatt U, VonVisger J, Nori U, Hasan A, Samavedi S, Andreoni KA, Henry ML, Pelletier RP, Rajab A, Elkhammas EA, Pesavento TE. 2012. Cardiac Stress Test as a Risk-Stratification Tool for Posttransplant Cardiac Outcomes in Diabetic Kidney Transplant Recipients.  Transplantation. Vol. 94, no. 12. (December): 1224-1229.
  • Singh N, Sun Q, Nadasdy T, Adams P, Dipaola NR, Pesavento T, Winters H, Satoskar A, Yu Z, Henry ML, Hadley GA, Pelletier RP. 2012. The Pathogenesis of Acute Allograft Dysfunction in Desensitized Renal Transplant Recipients.  Clin Transplant. Vol. 26, no. 4. (July): E402-11.
  • Pelletier RP, Rajab A, Henry ML. 2012. Reduced Graft Survival in African-American Kidney Recipients Correlates with De Novo Alloantibody Production and Not Acute Rejection. In American Transplant Congress
  • Casal P, Singh N, Wen X, Nicholson T, Theiss A, Brillson L, Lu W, Wang Y, Hadley G, Pelletier RP, Lee S. 2012. Application of ImmunoFET Technology to Detection of Proteins in Tissues and Fluids. In American Transplant Congress
  • Forbes R, Rajab A, Henry ML, Pelletier RP. 2012. Pulsatile Preservation Parameters in ECD and SCD Donor Kidneys. In American Transplant Congress
  • Pelletier RP, Rajab A, Bumgardner GL, Henry ML. 2012. Rapamycin Treatment Is Associated with Reduced Death and Graft Loss after Kidney Transplantation. In American Transplant Congress
  • Andreoni KA, Elkhammas EA, Rajab A, Pelletier RP, Bumgardner GL, Forbes R, Singh N, Von Visger J, Pesavento TE, Davies EA, Nori U, Henry ML. 2012. Influence of BMI and Age on Simultaneous Kidney-Pancreas Recipients. In American Transplant Congress
  • Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier RP, Ross P, Nadasdy T, Shilo K. 2012. Histological Spectrum of Pulmonary Manifestations in Kidney Transplant Recipients on Sirolimus Inclusive Immunosuppressive Regimens.  Diagnostic Pathology. Vol. 7, no. March: e25.
  • Adams P, DiPaola N, Kott M, Pelletier RP. 2012. Complementary Testing using Solid Phase and Flow Cytometry Technologies Provides Accurate Assessment of Preformed DSA. In 38th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI)
  • Ing SW, Sinnott LT, Donepudi S, Davies EA, Pelletier RP, Lane NE. 2011. Change in Bone Mineral Density at One Year Following Glucocorticoid Withdrawal Kidney Transplant Recipients.  Clin Transplant. Vol. 2, no. 25. (October): 113-123.
  • Pelletier RP, Reariek A, Hadley GA, Adams P. 2011. Solid Phase Crossmatch Help to Identify Flow Crossmatch Positive Patients at Minimal Risk for Transplantation. In American Transplant Congress
  • Singh N, Forbes RC, Andreoni KA, Rajab A, Henry ML, Pelletier RP, Pesavento TE. 2011. Living Donor Transplant Mitigates the Adverse Impact of Diabetes Status in Elderly (> 65 Years) Kidney Transplant Recipients. In American Transplant Congress
  • Pelletier RP, Rajab A, Pesavento TE, Henry ML. 2011. Clinical Variables Predictive of 1 and 3 Year Recipient Survival at a Single Center. In American Transplant Congress
  • Pelletier RP, Rajab A, Forbes R, Pesavento TE, Henry ML. 2011. Lack of Early CSA Exposure after Kidney Transplantation is a Risk Factor for De Novo Post-Transplant Alloantibody Production in African-Americans. In American Transplant Congress
  • Nadasdy T, Albawardi A, Singh N, Nadasdy G, Satoskar A, Brodsky S, Adams P, DiPaola N, Pelletier RP. 2011. IgG Subclass Distribution in Plasma Cells Infiltrating Renal Allografts in Plasma Cell Rich Late Acute Rejection (PCRLAR). In American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML. 2011. The Impact of Different Immunosuppressive Protocols on Early and Long Term Outcomes after Kidney Transplantation. In American Transplant Congress
  • Rajab A, Forbes R, Pelletier RP. 2011. The Incidence and Causes of Early Graft Losses in the Era of Hand-Assisted Laparoscopic Donor Nephrectomy. In American Transplant Congress
  • Rajab A, Henry ML, Pesavento TE, Pelletier RP. 2011. Incidence of Immunologic Complications after Renal Transplantation, When Using a Steroid Avoidance, Neoral and Sirolimus Immunosuppression Regimen, Is Increased in African-American Recipients. In American Transplant Congress
  • Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier RP, Nadasdy T, Shilo K. 2011. Histological Spectrum of Pulmonary Manifestations in Kidney Transplant Recipients. In 100th Annual Meeting United States-and-Canadian-Academy-of-Pathology
  • Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier RP, Nadasdy T, Shilo K. 2011. Histological Spectrum of Pulmonary Manifestations in Kidney Transplant Recipients. In 100th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology
  • Satoskar AA; Pelletier RP; Nadasdy GM; Henry ML; Ferguson RM; Nadasdy T. 2011. Histopathology and Outcome of Acute Humoral Rejection in Renal Allografts.  Frontiers in Bioscience (Scholar edition). Vol. 3, no. January: 919-928.
  • Inlow J, Steller P, Eltayeb A, Rearick A, Kott M, Adams P, Dipaola N, Pelletier RP. 2011. Case Study: Positive T-Cell Flow Crossmatch (TFXM)/Negative B-Cell Flow Crossmatch (BFXM) can be Mediated by a Class I Antibody. In 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Pelletier RP, Rajab A, Bumgardner GL, Andreoni KA, Elkhammas EA, Henry ML. 2011. Twenty-Five Year Evolution of Kidney Transplantation at The Ohio State University.  Clin Transplant. Vol. ?, no. January: 91-98.
  • Patrick A, Pelletier RP, Kott M, Dipaola N. 2011. Solid Phase Crossmatch Demonstrates 97% Agreement with Virtual Crossmatch. In 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Satoskar AA, Pelletier RP, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T. 2010. De Novo Thrombotic Microangiopathy in Renal Allograft Biopsies-Role of Antibody-Mediated Rejection.  Am J Transplantation. Vol. 10, no. 8. (July): 1804-1811.
  • Rajab A, Gunay Y, Pelletier RP, Elkhammas EA, Bumgardner GL, Andreoni KA, Henry ML. 2010. The Outcome of Percutaneous Nephrostomy Drainage and Ureteral Stenting for Treatment of Urological Complications after Transplantation. In 10th American Transplant Congress
  • Gunay Y, Rajab A, Henry ML, Pelletier RP. 2010. Decreased Morbidity with Laparoscopic Hernia Repair in Kidney and Kidney/Pancreas Transplant Recipients. In 10th American Transplant Congress
  • Gaughan A, Wang JJ, Anthony B, Pelletier RP, Brodsky S, Nadasdy T, Hadley GA. 2010. Tracking Host CD4 T Cells Responding to Renal Allografts. In 10th American Transplant Congress
  • Pelletier RP, Henry ML. 2010. Higher C2 CSA Levels within the First Month after Kidney Transplantation Correlates with Better Renal Function and Graft Survival at Five Years. In 10th American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML. 2010. A Long Term Outcome of Steroid Free, Calcineurin Inhibitor Free Maintenance Immunosuppression Based on Rapamune/Myfortic in Kidney Transplantation: A Prospective Study. In 10th American Transplant Congress
  • Rajab A, Samavedi S, Pelletier RP, Henry ML. 2010. The Impact of Early Sirolimus use on the Incidence of Wound Complications and Lymphocele in Renal Transplantation. In 10th American Transplant Congress
  • Pelletier RP, He X, Lu Z, Li CL, Rajab A, LEE MLT, Henry ML. 2010. Potential Shortcomings of the Scientific Registry of Transplant Recipients (SRTR) Center-Specific Kidney Transplant Outcomes Reporting. In 10th American Transplant Congress
  • Singh N, Adams P, Dipaola N, Rearick A, Gunay Y, Hadley GA, Pelletier RP. 2010. Solid Phase Testing Trumps Flow Cytometry Crossmatching in Renal Pretransplant Evaluations. In 10th American Transplant Congress
  • Pelletier RP, Hadley GA, Rearick A, Adams P. 2010. Solid Phase Crossmatch Helps to Identify Flow Crossmatch Positive Patients at Minimal Risk of Antibody Mediated Graft Injury after Transplantation. In 36th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Gaughan A, Wang JJ, Pelletier RP, Dipaola N, Adams P, Brodsky S, Nadasdy T, Hadley GA. 2010. Critical Role for Host Cells in Mixed Antibody Mediated Rejection or Renal Allografts. In 36th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Steller P, Adams P, Rearick A, Dipaola N, Hadley GA, Pelletier RP. 2010. Case Study: Discrepancies between DSA Specificity Assignments and Donor Crossmatches. In 36th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Pelletier RP. 2009. Detailed Outcomes Analyses are Essential for Optimizing Kidney Utilization Strategies.  Am J Transplantation. Vol. 9, no. 12. (October): 2653-2654.
  • Brodsky SV, Nadasdy GM, Pelletier RP, Satoskar A, Birmingham DJ, Hadley GA, Obeidat K, Nadasdy T. 2009. Expression of the Decay-Accelerating Factor (CD55) in Renal Transplants--A Possible Prediction Marker of Allograft Survival.  Am J Transplantation. Vol. 88, no. 4. (August): 457-464.
  • Pelletier RP, Hadley GA, Adams P, Henry ML, Zhangsheng Y, Ferguson RM. 2009. Even a Single, Remotely Positive Post-Transplant Alloantibody Test Correlates with Increased Chronic Allograft Nephropathy and Graft Loss after Kidney Transplantation.  Ibnosina Journal of Medicine and Biomedical Sciences. Vol. 1, no. 1. (July): 7-15.
  • Rees MA, Kopke JE, Pelletier RP, Segev DL, Rutter ME, Fabrega AJ, Rogers J, Pankewycz OG, Hiller J, Roth AE, Sandholm T, Unver MU, Montgomery RA. 2009. A Nonsimultaneous, Extended, Altruistic-Donor Chain.  The New England Journal Of Medicine. Vol. 360, no. 11. (March): 1096-1101.
  • Breimer ME, Rydberg L, Jackson AM, Lucas DP, Zachary AA, Melancon JK, Von Visger J, Pelletier RP, Saidman SL, Williams WW Jr, Holgersson J, Tydén G, Klintmalm GK, Coultrup S, Sumitran-Holgersson S, Grufman P. 2009. Multicenter Evaluation of a Novel Endothelial Cell Crossmatch Test in Kidney Transplantation.  Am J Transplantation. Vol. 87, no. 4. (February): 549-556.
  • Bickerstaff AA, Wang JJ, Pelletier RP, Nadasdy G, Rearick A, Dipaola N, Brodsky S, Nadasdy T, Hadley GA. 2009. Role of T Cells in Promoting Rejection of Renal Allografts during Mixed Antibody Mediated Rejection. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Rajab A, Elkhammas EA, Pelletier RP, Bumgardner GL, Andreoni KA, Henry ML. 2009. The Outcome of Simultaneous Pancreas-Kidney Transplantation from Older Donor. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Rearick A, Dipaola N, Hadley GA, Pelletier RP. 2009. Analysis of Reproducibility of Luminex Donor-Specific Antibody (DSA) Assay. In 35th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Rajab A, Obeidat K, Pelletier RP. 2009. The Safety and Efficacy of Hand-Assisted Laparoscopic Donor Nephrectomy. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Rajab A, Pelletier RP, Ferguson RM, Henry ML. 2009. A Prospective Study of Steroid Free, Calcineurin Inhibitor Free Maintenance Immunosuppression Based on Rapamune/Myfortic in Kidney Transplantation. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Pelletier RP, Adams P, DiPaula N, Rearick A, Hadley GA. 2009. The Luminex Anti-Donor HLA Class II Crossmatch Identifies Recipients at Low Immunological Risk for Renal Transplantation Despite a Positive B Cell Flow Crossmatch. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Brodsky SV, Pelletier RP, Nadasdy G, Satoskar A, Hadley GA, DiPaola N, Nadasdy T. 2009. Expression of the Decay Accelerating Factor (CD55) in Renal Transplants - A Possible Prediction Marker of Allograft Survival. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Rajab A, Pelletier RP, Ferguson RM, Henry ML. 2009. Long Term Outcome of Steroid Free Maintenance Immunosuppression with Sirolimus and Low Dose Cyclosporine in Kidney Transplantation. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Pelletier RP, Adams P, DiPaula N, Rearick A, Hadley GA. 2009. Comparison of Luminex Based Cross-Match (LXM) and Flow Cytometric Cross-Match (FXM) Results in Kidney Transplantation. In 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation
  • Rajab A, Pelletier RP, Henry ML, Bumgardner GL, Elkhammas EA, Ferguson RM. 2008. Long Term Outcome of Steroid Free Maintenance Immunosuppression with Sirolimus and Low Dose Cyclosporine in Primary kidney Transplantation. In 8th American Transplant Congress
  • Satoskar AA, Nadasdy G, Pelletier RP, Henry ML, Lehman A, Ferguson RM, Nadasdy T. 2008. Correlation of Histopathologic Features with Graft Outcome in C4D Positive Early Acute Antibody-Mediated Rejection in Non-Desensitized Renal Allografts to Guide Therapy. In 8th American Transplant Congress
  • Bickerstaff AA, Pelletier RP, Wang JJ, Nadasdy G, DiPaola N, Orosz CG, Satoskar A, Hadley GA, Nadasdy T. 2008. An Experimental Model of Acute Humoral Rejection of Renal Allografts Associated with Concomitant Cellular Rejection.  Am J Pathology. Vol. 173, no. 2. (May): 347-357.
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 2008. A Prospective Study of Steroid Free, Calcineurin Inhibitor Free Maintenance Immunosuppression based on Rapamune/Myfortic in Kidney Transplantation. In 8th American Transplant Congress
  • Gaughan A, Wang JJ, Nadasdy G, Nadasdy T, Adams P, Pelletier RP, Hadley GA. 2008. Acute Humoral Rejection of Renal Allografts is T Cell Dependent. In 8th American Transplant Congress
  • Pelletier RP, Satoskar A, Sun Q, Nadasdy G, Nadasdy T, Rajab A, Ferguson RM. 2008. Implementation of a Steroid-Free, Rapamycin and Neoral Maintenance Immunosuppression Regimen Reduces Acute Cellular Rejection (ACR) but not Acute Humoral Rejection (AHR). In 8th American Transplant Congress
  • Gaughan A, Fukuzawa N, Wang JJ, Pelletier RP, Nadasdy,Gyongyi; Nadasdy T, Hadley GA, Fairchild R. 2008. Acute Humoral Rejection of Renal Allografts in CCR5-Deficient Recipients. In 8th American Transplant Congress
  • Sun Q, Pelletier RP, Adams P, Nadasdy T, Hadley GA, Ferguson RM. 2008. The Natural History of Antibody-Mediated Rejection in kidney transplantation: A prospective observation based on desensitized recipients. In 8th American Transplant Congress
  • Bickerstaff AA, Nozaki T, Wang JJ, Pelletier RP, Hadley G, Nadasdy G, Nadasdy T, Fairchild RL. 2008. Acute Humoral Rejection of Renal Allografts in CCR5 (-/-) Recipients.  Am J Transplantation. Vol. 8, no. 3. (February): 557-566.
  • Adams P, Rearick A, Pelletier RP. 2008. Simple Modification to the DSA Assay Reduces High IGG Background Binding in the Donor-Reactive Solid-Phase Crossmatch. In 34th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Rajab A, Pelletier RP, Henry ML. 2008. Perfusion and Storage Techniques. In Organ Preservation for Transplantation. Edited by Luis Toledo. Austin: Landes Bioscience.
  • Pelletier RP, Rearick A, Adams PW. 2008. Case Study: Retrospective Analysis by DSA Luminex Crossmatch in a Failing Renal Transplant. In 34th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Pelletier RP, Rearick A, Adams PW. 2008. Is there an Increased Risk to Graft Outcome in Patients with Pretransplant Flow B Positive Crossmatches that are Negative in the Class II DSA Luminex Crossmatch?. In 34th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Rajab A, Pelletier RP, Ferguson RM, Elkhammas EA, Bumgardner GL, Henry ML. 2007. Steroid-Free Maintenance Immunosuppression with Rapamune and Low-Dose Neoral in Pancreas Transplant Recipients.  Am J Transplantation. Vol. 84, no. 9. (November): 1131-1137.
  • Hasan M, Rajab A, Pelletier RP. 2007. Hand assisted donor nephrectomy in donor with BMI > 30.
  • Hasan M, Rajab A, Pelletier RP. 2007. Hand assisted donor nephrectomy using pfannenstiel incision.
  • Hasan M, Rajab A, Pelletier RP. 2007. Hand Assisted Donor Nephrectomy has a Lower Rate of Conversion than Total Laparoscopic Procedures.
  • Hasan M, Rajab A, Pelletier RP. 2007. Hand Assisted Right Donor Nephrectomy.
  • Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T. 2007. Peritubular Capillary C4d Staining in Late Acute Renal Allograft Rejection--Is it Relevant?.  Clin Transplant. Vol. 22, no. 1. (September): 61-67.
  • Ing SW, Sinnott LT, Davies EA, Pelletier RP. 2007. Bone Mineral Density Changes in a Prospective, Randomized Trial of Steroid withdrawal in Kidney Transplant Recipients. In 7th American Transplant Congress
  • Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T. 2007. Peritubular Capillary C4D Staining in Late Acute Renal Allograft Rejection - Is it Relevant?. In 7th American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 2007. Kidney Retransplantation using a Rapamune based, Steroid Sparing Immunosuppressive Protocol. In 7th American Transplant Congress
  • Ferguson RM, Henry ML, Pelletier RP, Rajab A. 2007. Efficacy and Tolerability of Steroid-Free Maintenance Immunosuppression with Sirolimus and Reduced-Dose Neoral - Three to Five Year Follow-up. In 7th American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 2007. Steroid Free Maintenance Immunosuppression with Rapamune and Low Dose Neoral in Pancreas Transplant Recipients. In 7th American Transplant Congress
  • Satoskar AA, Nadasdy G, Nadasdy T, Ferguson RM, Pelletier RP. 2007. Steroid Avoidance Correlates with a Decreased Incidence of C4D Positive Biopsies in the First Post-Transplant. In 7th American Transplant Congress
  • Jackson AM, Zachary AA, Breimer ME, Rydberg L, Klimmalm GB, Smith DM, Pelletier RP, Von Visger J, Williams WW, Saidman SL, Holgersson J, Tyden G, Holgersson S, Grufman P. 2007. Clinical Trial Data Evaluating the XM-One Endothelial Cell Crossmatch Test in Predicting Early Rejection Episodes in Renal Transplantation. In 7th American Transplant Congress
  • Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Rajab A, Ferguson RM. 2007. Single Center Experience of PTLD after Kidney and Kidney/Pancreas Transplantation. In 7th American Transplant Congress
  • Pelletier RP, Adams P, Ferguson RM. 2007. Rituximab does not Interfere in a Solid Phase Donor-Specific Crossmatch (DSA) Assay. In 7th American Transplant Congress
  • Bickerstaff AA, Nozaki T, Pelletier RP, Wang JJ, Nadasdy T, Orosz CG, Fairchild RL. 2007. Acute Humoral Rejection of Renal Allografts in CCR5-Deficient Recipients. In 7th American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 2007. A Prospective Study of Steroid Free, Calcinurein Inhibitor Free Maintenance Immunosuppression based on Rapamune/Myfortic in Kidney Transplantation, an Interim Analysis. In 7th American Transplant Congress
  • Henry ML, Pelletier RP, Rajab A, Ferguson RM, Patel H, Mahan J, Mentser M. 2007. Steroid Free Immunosuppression in the Pediatric Renal Transplant Recipient. In 7th American Transplant Congress
  • Rajab A, Pelletier RP, Henry ML, Ferguson RM. 2007. The Impact of Sirolimus on the Incidence of Wound Complications and Lymphocele in Renal Transplantation. In 7th American Transplant Congress
  • Rajab A, Warrick J, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 2007. The Effects of Obesity on Renal Transplant Recipients. In 7th American Transplant Congress
  • Pelletier RP, Soule J, Henry ML, Rajab A, Ferguson RM. 2007. Clinical Outcomes of Renal Transplant Recipients Treated with Enteric-Coated Mycophenolic Acid VS Mycophenolate Mofetil as a Switch Agent Using a Primary Steroid-Free Rapamune and Microemulsion Cyclosporine Protocol.  Clin Transplant. Vol. 21, no. 4. (April): 532-535.
  • Pelletier RP, Bickerstaff AA, Adams PW, Orosz CG. 2007. Evaluation of Immune Regulation in Transplant Patients using the Trans Vivo Delayed Type Hypersensitivity Assay.  Human Immunology. Vol. 68, no. 6. (March): 514-522.
  • Adams P, Pelletier RP. 2007. Rituximab does not Interfere in a Solid Phase Donor-Specific Crossmatch (DSA) Assay. In 33rd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Pelletier RP, Diderrich GT. 2007. A Note on Breiman's Random Forest Data Mining Technique and Conventional Cox Modeling of Survival Statistics: The Case of the Phantom "Induct" Covariate in The Ohio State University Kidney Transplant Database.  Communications in Statistics Theory and Methods. Vol. 36, no. January: 1953-1964.
  • DiPaola NR, Adams PW, Nghiem DD, Parris GL, Pelletier RP, Orosz CG. 2006. Comparison of Alloantibody Detected in Peripheral Blood and Nephrectomized Human Renal Allografts. In 32nd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics
  • Pelletier RP, Nadasdy T, Nadasdy G, Satoskar A, Tewari A, Cotril J, Henry ML, Rajab A, Ferguson RM. 2006. Acute Renal Failure following Kidney Transplantation Assoicated with Myoglobinuria in Patients Treated with Rapamycin.  Am J Transplantation. Vol. 82, no. 5. (September): 645-650.
  • Rajab A, Pelletier RP, Henry ML, Ferguson RM. 2006. Excellent Clinical Outcomes in Primary Kidney Transplant Recipients Treated with Steroid-Free Maintenance Immunosuppression.  Clin Transplant. Vol. 20, no. 5. (September): 537-546.
  • Satoskar AA, Nadasdy GM, Sedmak D, Pelletier RP, Ferguson RM, Nadasdy T. 2006. Peritubular Capillary C4D Deposition in Chronic Renal Allograft Rejection - How Relevant is it?. In 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology
  • Satoskar AA, Nadasdy GM, Sedmak D, Pelletier RP, Ferguson RM, Nadasdy T. 2006. Peritubular capillary C4d deposition in chronic renal allograft rejection - How relevant is it?. In 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology
  • Nadasdy G, Bott C, Cowden D, Pelletier RP, Ferguson RM, Nadasdy T. 2005. Comparative Study for the Detection of Peritubular Capillary C4d Deposition in Human Renal Allografts using Different Methodologies.  Human Pathology. Vol. 36, no. 11. (October): 1178-1185.
  • Pelletier RP, Baris A, Ferguson RM. 2005. Prospective, Randomized Trial of Steroid Withdrawal in Kidney Recipients Treated with Mycophenolate Mofetil and Cyclosporine.  Clin Transplant. Vol. 20, no. 1. (September): 10-18.
  • Denny JE, Elkhammas EA, Henry ML, Ferguson RM, Bumgardner GL, Pelletier RP, Rajab A. 2005. Steroid Avoidance in Liver Transplantation. In 11th Annual Meeting of the International-Liver-Transplant-Society
  • Pelletier RP, Ferguson RM. 2005. Potential Accommodation in XM Plus Living Donor Kidney Recipients following Pre-transplant Desensitization. In 6th American Transplant Congress
  • Elkhammas EA, Henry ML, Ferguson RM, Bumgardner GL, Pelletier RP, Rajab A. 2005. Steroid Avoidance in Liver Transplantation. In 6th American Transplant Congress
  • Salazar A, Pelletier RP, Yilmaz S, Monroy-Cuadros M, Tibbles LA, McLaughlin K, Sepand JF. 2005. Use of a Minimally Invasive Donor Nephrectomy Program to Select Technique for Live Donor Nephrectomy. In 91st Annual Meeting of the North-Pacific-Surgical-Association
  • Rajab A, Mahoney JE, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM, Pelletier RP. 2005. Hand-Assisted Laparoscopic Versus Open Nephrectomies in Living Donors. In 19th International Congress of the Transplantation-Society
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Davies EA, Orosz CG, Ferguson RM. 2005. Evolution of Immunosuppression in Kidney Transplantation: The Ohio State University Experience.  Clin Transplant. Vol. 1, no. January: 111-117.
  • Bergese SD, Pelletier RP, Ferguson RM, Orosz CG. 2005. Graft Endothelial VCAM-1 is not Necessary for Acute Cardiac Allograft Rejection in Mice. In Transplant Proceedings
  • Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Davies EA, Orosz CG, Ferguson RM. 2005. Evolution of Immunosuppression in Kidney Transplantation: The Ohio State University Experience. In Clinical Transplant. Edited by Cecka and Terasaki, Eds. Los Angeles: UCLA Immunogenetics Center.
  • Elkhammas EA, Henry ML, Ferguson RM, Bumgardner GL, Pelletier RP, Rajab A, Davies EA. 2004. Simultaneous Pancreas-Kidney Transplantation: Overview of The Ohio State Experience.  Yonsei Medical Journal. Vol. 45, no. 6. (December): 1095-1100.
  • Akin EB, Vitellas KM, Rajab A, Pelletier RP, Davies EA, Bumgardner GL, Henry ML, Ferguson RM, Elkhammas EA. 2004. Magnetic Resonance Cholangiography with Mangafodipir Trisodium (Teslascan) to Evaluate Bile Duct Leaks after T-Tube Removal in Liver Transplantation.  J Comput Assist Tomogr. Vol. 28, no. 5. (October): 613-616.
  • Dierksheide J, Baiocchi R, Ferketich A, Roychowdhury S, Pelletier RP, Eisenbeis C, Caligiuri M, VanBuskirk A. 2004. IFN-Gamma Gene Polymorphisms Associate with Development of EBV+ Lymphoproliferative Disease in Hu PBL-SCID Mice.  Blood. Vol. 105, no. 4. (October): 1558-1565.
  • Rajab A, Khabiri H, Pelletier RP, Henry ML, Akin B, Elkhammas EA, Bumgardner GL, Ferguson RM. 2004. Magnetic Resonance Angiography for Preoperative Evaluation of Potential Kidney Donors. In 4th Annual Meeting of the American-Transplant-Congress
  • Rajab A, Khabiri H,Pelletier RP, Henry ML, Akin B, Elkhammas E, Bumgardner G, Ferguson RM. 2004. Magnetic Resonance Angiography for Preoperative Evaluation of Potential Kidney Donors.  JSR. Vol. 120, no. 2. (July): 195-200.
  • Henry ML, Pelletier RP. 2004. Experience with Simulect.  Transplantation Proceedings. Vol. 36, no. 2 Suppl. (March): 471S-474S.
  • Akin B, Ferguson RM, Pelletier RP. 2004. Five Year follow-up after Steroid withdrawal Demonstrates No Evidence of Worsening Renal Function. In 5th American Transplant Congress
  • Cosio FG, Nuovo M, Delgado L, Yearsley M, Porcu P, Caligiuri M, Pelletier RP, Nuovo G. 2003. EBV Kidney Allograft Infection: Possible Relationship with a Peri-graft Localization of PTLD.  Am Journal of Transplantation. Vol. 4, no. 1. (November): 116-123.
  • Rajab A, Mahoney JE, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM, Pelletier RP. 2003. Hand-Assisted Laparoscopic Versus Open Nephrectomies in Living Donors.  Canadian Journal of Surgery. Journal canadien de chirurgie. Vol. 48, no. 2. (September): 123-130.
  • Benjamin R, Hochberg F, Fox E, Bungay P, Elmquist W, Stewart C, Gallo J, Collins J, Pelletier RP, de Groot J, Hickner R, Cavus I, Grossman S, Colvin O. 2003. Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium.  Neuro Oncology. Vol. 6, no. 1. (September): 65-74.
  • Ferguson RM, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Pelletier RP, Rajab AR. 2003. Twenty Years of Renal Transplantation at The Ohio State University: The Results of Five Eras of Immunosuppression.  Am J Surg. Vol. 186, no. 3. (August): 306-311.
  • Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, Ferguson RM. 2003. The Impact of Mycophenolate Mofetil Dosing Patterns on Clinical Outcome after Renal Transplantation.  Clin Transplant. Vol. 17, no. 3. (May): 200-205.
  • Elkhammas EA, Henry ML, Akin B, Ferguson RM, Bumgardner GL, Davies EA, Pelletier RP, Rajab A. 2003. Simultaneous Pancreas-Kidney Transplantation at a Single Center.  Clin Transplant. Vol. n/a, no. January: 221-227.
  • Pelletier RP, Hennessy PK, Adams PW, Orosz CG. 2002. High Incidence of Donor-Reactive Delayed-Type Hypersensitivity Reactivity in Transplant Patients.  Am J Transplantation. Vol. 2, no. 10. (November): 926-933.
  • Hanaway MJ, Buell JF, Koffron A, Kaufman D, Bruce D, Pelletier RP, Henry ML, Stratta R, Gaber AO, James L, Alloway RR, First MR, Trofe J, Beebe TM, Peddi VR, Woodle ES. 2002. PTLD in Pancreas Transplantation: A Multicenter Analysis.
  • Cosio FG, Pesavento TE, Pelletier RP, Henry ML, Ferguson RM, Kim S, Lemeshow S. 2002. Patient Survival after Renal Transplantation III: The Effects of Statins.  Am J Kidney Dis. Vol. 40, no. 3. (September): 638-643.
  • Cosio FG, Nuovo GJ, Delgado L, Porcu P, Nuovo M, Pelletier RP. 2002. Infection of Kidney Allografts with Epstein-Barr virus (EBV) is Highly Correlated with Post-Transplant Lymphoproliferative Disorder (PTLD).
  • Porcu P, Eisenbeis CF, Pelletier RP, Davies EA, Baiocchi RA, Roychowdhury S, Vourganti S, Nuovo GJ, Marsh WL, Ferketich AK, Henry ML, Ferguson RM, Caligiuri MA. 2002. Successful Treatment of Posttransplantation Lymphoproliferative Disorder (PTLD) following Renal Allografting is Associated with Sustained CD8(+) T-Cell Restoration.  Blood. Vol. 100, no. 7. (June): 2341-2348.
  • Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. 2002. The Graft Helps to Define the Character of the Alloimmune Response.  Transplant Immunology. Vol. 9, no. 2-4. (May): 137-141.
  • Orosz CG, Bickerstaff AA, Adams P, Hennessy P, Pelletier RP. 2002. Evidence that a Similar Range of Alloimmune Responses Can Develop in Murine and Human Allograft Recipients.  Transplant Immunology. Vol. 9, no. 2-4. (May): 143-147.
  • Pelletier RP, Hennessy PK, Adams PW, VanBuskirk AM, Ferguson RM, Orosz CG. 2002. Clinical Significance of MHC-Reactive Alloantibodies that Develop after Kidney or Kidney-Pancreas Transplantation.  Am J Transplantation. Vol. 2, no. 2. (April): 134-141.
  • Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM. 2001. A Randomized Prospective Trial of OKT3 Induction in the Current Immunosuppression Era.  Clin Transplant. Vol. 15, no. 6. (December): 410-414.
  • Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Ferguson RM. 2001. A Single Center Experience with Basiliximab Induction Therapy in Renal Transplantation.  Transplantation Proceedings. Vol. 33, no. 7-8. (December): 3178-3179.
  • Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Ferguson RM. 2001. A Single Center Experience with Basiliximab Induction Therapy in Renal Transplantation. In Congress on Transplant Odyssey
  • Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. 2001. Murine Renal Allografts: Spontaneous Acceptance is Associated with Regulated T Cell-Mediated Immunity.  J. Immunol. Vol. 167, no. 9. (November): 4821-4827.
  • VanBuskirk AM, Malik V, Xia D, Pelletier RP. 2001. A Gene Polymorphism Associated with Posttransplant Lymphoproliferative Disorder.  Transplant Proceedings. Vol. n/a, no. 33. (March): 1-2.
  • VanBuskirk AM, Malik V, Xia D, Pelletier RP. 2001. A Gene Polymorphism Associated with Posttransplant Lymphoproliferative Disorder. In 18th World Congress of the Transplantation-Society
  • Orosz CG, Hennessy P, Adams P, Pelletier RP. 2001. Detection of Human Cellular Alloimmunity by DTH Reactivity to HLA-coated Beads. In Visuals of the Clinical Histocompatibility Workshop
  • Orosz CG, Hennessy P, Adams P, Pelletier RP. 2001. Expression of Cellular Alloimmunity in Transplant Recipients. In Visuals of the Clinical Histocompatibility Workshop
  • Orosz CG, Hennessy P, Adams P, Pelletier RP. 2001. Expression of Cellular vs. Humoral Alloimmunity in Transplant Recipients. In Visuals of the Clinical Histocompatibility Workshop
  • Cosio FG, Pelletier RP, Henry ML, Ferguson RM, Mitchell L, Lemeshow S. 2000. Elevated Blood Pressure Predicts the Risk of Acute Rejection in Renal Allograft Recipients.  Kidney International. Vol. 59, no. 3. (September): 1158-1164.
  • Pelletier RP, Pravica V, Perrey C, Xia D, Ferguson RM, Hutchinson I, Orosz CG. 2000. Evidence for a Genetic Predisposition Towards Acute Rejection following Kidney and Simultaneous Kidney-Pancreas Transplantation.  Transplantation. Vol. 70, no. 4. (August): 674-680.
  • VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG. 2000. Human Allograft Acceptance is Associated with Immune Regulation.  The Journal of Clinical Investigation. Vol. 106, no. 1. (May): 145-155.
  • Pelletier RP, Pravica V, Perrey C, Xia DY, Ferguson RM, Hutchinson I, Orosz CG. 2000. Cytokine Genotype Impacts Clinical Outcome in Transplant Recipients.
  • Henry ML, Tso P, Elkhammas EA, Davies EA, Pelletier RP, Bumgardner GL, Ferguson RM. 2000. Immediate Renal Allograft Function following Pulsatile Preservation.
  • Cosio FG, Pesavento TE, Falkenhain MA, Pelletier RP, Ferguson RM. 2000. The Use of Statins Correlates, with Improved Renal Allograft Survival, an Effect Independent of Cholesterol Levels.
  • Pelletier RP, Bumgardner GL, Davies EA, Elkhammas EA, Henry ML, Ferguson RM. 2000. Delayed Cyclosporine Administration following Simulect Induction does not Increase Acute Rejection in Renal Transplant Recipients.
  • Pelletier RP, Hennessy PK, Cosio FG, Ferguson RM, Orosz CG. 2000. Disasterous Consequences of Post-Transplant Alloantibody Development.
  • Pesavento TE, Pelletier RP, Henry ML, Ferguson RM, Cosio FC. 2000. Improved Patient Survival in High Risk Renal Transplant (RTx) Recipients Treated with HMG CoA Reductase Inhibitors (HMG): An Effect Independent of Serum Lipid Levels.
  • Spetie DN, Cosio FG, Haller LU, Frankel WL, Pelletier RP, Pesavento TE. 2000. Evidence for Glomerular Disease during Acute Renal Allograft Rejection.
  • VanBuskirk AM, Malik V, Xia DY, Pelletier RP. 2000. Gene Polymorphism Associated with Early-Onset Post-Transplant Lymphoproliferative Disorder (PTLD).
  • Pelletier RP, Hennessy PK, Cosio FG, Ferguson RM, Orosz CG. 2000. Unexpectedly High Frequency of Anti-MHC Class II Alloantibodies in Transplant Recipients.
  • Elkhammas EA, Henry ML, Demirag A, Carmona MM, Bumgardner GL, Pelletier RP, Ferguson RM. 2000. Basiliximab vs OKT3 in Primary Simultaneous Pancreas-Kidney Transplant Recipients.
  • Pelletier RP, Davies EA, Elkhammas EA, Bumgardner GL, Henry ML, Ferguson RM. 2000. Randomized, Prospective Trial of Prednisone withdrawal in Stable Renal Transplant Recipients.
  • Elkhalammas EA, Henry ML, Demirag A, Carmona MM, Bumgardner GL, Pelletier RP, Feguson RM. 2000. Basiliximab vs OKT3 in Liver Transplantation.
  • Pelletier RP, Davies EA, Elkhammas EA, Bumgardner GL, Henry ML, Ferguson RM. 2000. Improved Outcome in Renal Transplant Recipients Treated with Simulect Versus OKT3 Induction.
  • Bickerstaff AA, Xia D, Pelletier RP, Orosz CG. 2000. Mechanisms of Graft Acceptance: Evidence that Plasminogen Activator Controls Donor-Reactive Delayed-Type Hypersensitivity Responses in Cardiac Allograft Acceptor Mice.  J. Immunol. Vol. 164, no. 10. (March): 5132-5139.
  • Pesavento TE, Henry ML, Falkenhain ME, Cosio FG, Bumgardner GL, Elkhammas EA, Pelletier RP, Ferguson RM. 1999. Obese Living Kidney Donors: Short-term Results and Possible Implications. In 16th Annual Meeting of the American-Society-of-Transplant-Physicians
  • Cosio FG, Pelletier RP, Sedmak DD, Pesavento TE, Henry ML, Ferguson RM. 1999. Renal Allograft Survival following Acute Rejection Correlates with Blood Pressure Levels and Histopathology. In International Congress of Transplantation
  • Pesavento TE, Henry ML, Falkenhain ME, Cosio FG, Bumgardner GL, Davies EA, Elkhammas EA, Pelletier RP Ferguson RM. 1999. Obese Living Kidney Donors: Short-Term Results and Possible Implications.  Transplantation. Vol. 68, no. 10. (November): 1491-1496.
  • Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM. 1999. Focal Segmental Glomerulosclerosis in Renal Allografts with Chronic Nephropathy: Implications for Graft Survival.  Am J Kidney Dis. Vol. 34, no. 4. (October): 731-738.
  • Elkhammas EA, Carmona MM, Henry ML, Bumgardner GL, Pelletier RP, Ferguson RM. 1999. Basiliximab and OKT3 in Liver Transplantation.
  • Demirag A, Elkhammas EA, Henry ML, Davies EA, Pelletier RP, Bumgardner GL, Dorner B, Ferguson RM. 1999. Pulmonary Rhizopus Infection in a Diabetic Renal Transplant Recipient.  Clin Transplant. Vol. 14, no. 1. (July): 8-10.
  • Cosio FG, Pelletier RP, Sedmak DD, Pesavento TE, Henry ML, Ferguson RM. 1999. Renal Allograft Survival following Acute Rejection Correlates with Blood Pressure Levels and Histopathology.  Kidney International. Vol. 56, no. 5. (June): 1912-1919.
  • Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM. 1999. IL-2r Antibody Induction with Delayed Neoral Therapy.
  • Burngardner GL, Henry ML, Elkhammas EA, Sherman T, Bowen G, Davies EA, Pelletier RP, Jones L, Ferguson RM. 1999. Early Graft Function after in Situ LR followed by Backtable Organ Perfusion with UW.
  • Schlossberg M, Bumgardner GL, Henry ML, Elkhammas EA, Pelletier RP, Davies EA, Ferguson RM. 1999. Comparison of Non-Lipitor and Lipitor Therapy for Treatment of Hyperlipidemia in Kidney Transplant Recipients.  Transplantation. Vol. 9, no. 67. (May): e304.
  • Schlossberg M, Bumgardner GL, Henry ML, Elkhammas EA, Pelletier RP, Davies EA, Ferguson RM. 1999. Comparison of Non-Lipitor and Lipitor Therapy for Treatment of Hyperlipidemia in Kidney Transplant Recipients.
  • Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM. 1999. IL 2R Antibody Induction with Delayed Neoral Therapy.  Transplantation. Vol. n/a, no. 67. (May): e304.
  • Pelletier RP, Adams Patrick W, Hennessy Patrice K, Orosz Charles G. 1999. Comparison of Crossmatch Results Obtained by ELISA, Flow Cytometry, and Conventional Methodologies.  Human Immunology. Vol. 60, no. 9. (May): 855-861.
  • Bumgardner GL, Henry ML, Elkhammas EA, Sherman T, Bowen G, Davies EA, Pelletier RP, Jones L, Ferguson RM. 1999. Early Graft Function after in Situ LR followed by Backtable Organ Perfusion with UW.  Transplantation. Vol. S653, no. 67. (May): e443.
  • Pelletier RP, Davies EA, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 1999. Changes in the Clinical Characteristics of Post Transplant Lymphoproliferative Diseas (PTLD) in Kindey and Simultaneous Pancreas/Kidney Recipients (SPK).  Transplantation. Vol. 9, no. 67. (May): e315.
  • Pelletier RP, Davies EA, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 1999. Changes in the clinical characteristics of post transplant lymphoproliferative disease (PTLD) in kidney and simultaneous pancreas-kidney recipients (SPK).
  • Elkhammas EA, Henry ML, Carmona MM, Bumgardner GL, Pelletier RP, Ferguson RM. 1999. Simulect and Delayed Neoral in Liver and Kidney/Pancreas Transplantation.  Transplantation. Vol. 9, no. 67. (May): e358.
  • Elkhammas EA, Henry ML, Carmona MM, Burngardner GL, Pelletier RP, Ferguson RM. 1999. Simulect and Delayed Neoral in Liver and Kidney Pancreas Transplantation.
  • VanBuskirk AM, Pelletier RP, Carrodeguas L, Orosz CG. 1999. Trans-vivo Assessment or Human Alloreactive DTH Responses. A Tool for Post-transplant Monitoring.
  • Cosio FG, Pelletier RP, Sedmak DD, Ferguson RM. 1999. Renal Allograft (Tx) Survival after Acute Rejection(AR) Correlates with Blood Pressure Levels (BP).
  • Cosio FG, Pelletier RP, Sedmak DD. 1999. Predictive Value of Histopathology and Function on Outcome of Renal Allografts after Acute Rejection.  Transplantation Proceedings. Vol. 31, no. 1-2. (April): 261-263.
  • Cosio FG, Pelletier RP, Pesavento TE, Falkenhain ME, Ferguson RM. 1999. Elevated Blood Pressure (BP) Levels Predict the Risk of Acute Rejection (AR) after Renal Transplantation (Tx).
  • Cosio FG, Pelletier RP, Sedmak DD, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. 1999. Pathologic Classification of Chronic Allograft Nephropathy: Pathogenic and Prognostic Implications.  Transplantation. Vol. 67, no. 5. (March): 690-696.
  • Cosio FG, Pelletier RP, Sedmak DD. 1999. Predictive Value of Histopathology and Function on Outcome of Renal Allografts after Acute Rejection. In XVIIth World Congress of the Transplantation-Society
  • Pelletier RP, Henry ML. 1999. Kidney Transplantation. In Prognosis and Outcome Expectancy of Surgical Diseases. Edited by McKellar DP and Reilling RB. n/a: McKellar DP and Reilling RB.
  • Pelletier RP, Orosz CG, Cosio F, Ferguson RM. 1999. Risk Factors in Chronic Rejection.  Current Opinion in Organ Transplantation. Vol. 4, no. January: 28-34.
  • Andreoni KA, Pelletier RP, Elkhammas EA, Davies EA, Bumgardner GL, Henry ML, Ferguson RM. 1999. Increased Incidence of Gastrointestinal Surgical Complications in Renal Transplant Recipients with Polycystic Kidney Disease.  Transplantation. Vol. 67, no. 2. (January): 262-266.
  • Andreoni KA, Pelletier RP, Elkhammas EA, Davies EA, Bumgardner GL, Henry ML, Ferguson RM. 1999. Increased Incidence of Gastrointestinal Surgical Complications in Renal Transplant Recipients with Polycystic Kidney Disease. In 24th Annual Meeting of the American-Society-of-Transplant-Surgeons
  • Pelletier RP, Cosio F, Henry ML, Bumgardner GL, Davies EA, Elkhammas EA, Ferguson RM. 1998. Acute Rejection following Renal Transplantation. Evidence that Severity is the Best Predictor of Subsequent Graft Survival Time.  Clin Transplant. Vol. 12, no. 6. (December): 543-552.
  • Cosio FG, Pesavento TE, Sedmak DD, Farhan N, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM. 1998. Clinical Implications of the Diagnosis of Renal Allograft Infarction by Percutaneous Biopsy.  Transplantation. Vol. 66, no. 4. (August): 467-471.
  • Melvin WS, Meier DJ, Elkhammas EA, Bumgardner GL, Davies EA, Henry ML, Pelletier RP, Ferguson RM. 1998. Prophylactic Cholecystectomy is not Indicated following Renal Transplantation.  Am J Transplantation. Vol. 175, no. 4. (April): 317-319.
  • Henry ML, Elkhammas EA, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Outcome of 300 Consecutive Pancreas-Kidney Transplants.  Transplantation Proceedings. Vol. 30, no. 2. (March): 291-291.
  • Elkhammas EA, Yilmaz S, Henry ML, Yenchar J, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Simultaneous Pancreas/Kidney Transplantation: Comparison of Mycophenolate Mofetil Versus Azathioprine.  Transplantation Proceedings. Vol. 30, no. 2. (March): 512-512.
  • Henry ML, Elkhammas EA, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Outcome of 300 Consecutive Pancreas-Kidney Transplants. In 6th Congress of the International-Pancreas-and-Islet-Transplant-Association
  • Elkhammas EA, Yilmaz S, Henry ML, Yenchar J, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Simultaneous Pancreas/Kidney Transplantation: Comparison of Mycophenolate Mofetil versus Azathioprine. In 6th Congress of the International-Pancreas-and-Islet-Transplant-Association
  • Elkhammas EA, Henry ML, Yilmaz S, Pelletier RP, Bumgardner GL, Ferguson RM. 1998. Simultaneous Pancreas-Kidney Transplantation at The Ohio State University Medical Center. In Clinical Transplants 1997. Edited by Cecka and Terasaki. Columbus: Cecka and Terasaki.
  • Cosio FG, Elkhammas EA, Henry ML, Pesavento TE, Sedmak DD, Pelletier RP, Bumgardner GL, Ferguson RM. 1998. Function and Survival of Renal Allografts from the Same Donor Transplanted into Kidney-Only or Kidney-Pancreas Recipients.  Transplantation. Vol. 65, no. 1. (January): 93-99.
  • Elkhammas EA, Yilmaz S, Henry ML, Yenchar J, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine. In Transplant Proceedings
  • Henry ML, Elkhammas EA, Bumgardner GL, Pelletier RP, Ferguson RM. 1998. Outcome of 300 consecutive pancreas-kidney transplants. In Transplant Proceedings
  • Orosz CG, Pelletier RP. 1997. Chronic Remodeling Pathology in Grafts.  Current Opinion in Immunology. Vol. 9, no. 5. (October): 676-680.
  • Pelletier RP, Grauer D, Zagari M, Nunez S, DiCesare J, Ferguson RM. 1997. An Assessment of Outcomes Associated with Conversion to Neoral in Cadaveric Renal Transplant Patients.
  • Cosio FG, Pelletier RP, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. 1997. Impact of Acute Rejection and Early Allograft Function on Renal Allograft Survival.  Transplantation. Vol. 63, no. 11. (June): 1611-1615.
  • Pelletier RP, Orosz CG, Adams PW, Bumgardner GL, Davies EA, Elkhammas EA, Henry ML, Ferguson RM. 1997. Clinical and Economic Impact of Flow Cytometry Crossmatching in Primary Cadaveric Kidney and Simultaneous Pancreas-Kidney Transplant Recipients.  Transplantation. Vol. 63, no. 11. (June): 1639-1645.
  • Elkhammas EA, Henry ML, Yilmaz S, Pelletier RP, Bumgardner GL, Ferguson RM. 1997. Simultaneous Pancreas-Kidney Transplantation at The Ohio State University Medical Center.  Clin Transplant. Vol. n/a, no. January: 167-172.
  • Hennessy PK, Adams PW, Pelletier RP, Orosz CG. 1997. Characteristics and Clinical Significance of AB Detectable by ELISA-PRA.
  • Hennessy PK, Adams PW, INLOW JC, Schrader PS, Westerkamp JM, Pelletier RP, Orosz CG. 1997. Comparison of Sensitivity, Reproducibility, and Test Agreement between Amos-modified, AGH, ELISA, and Flow Cytometry Crossmatch Methodologies.
  • Pelletier RP, Elkhammas EA, Henry ML, Ferguson RM. 1996. Update on the Status of Pancreas-Kidney Transplantation.  Current Opinion in Nephrology and Hypertension. Vol. 5, no. 6. (November): 504-507.
  • Adams PW, Pelletier RP, Orosz CG. 1996. Cost Benefit Analysis of T Cell Flow Cytometry Crossmatching.
  • Dahmen U, Bergese SD, Quian S, Pelletier RP, Wu H, Sedmak DD, Fung JJ, Orosz CG. 1995. Patterns of Inflammatory Vascular Endothelial Changes in Murine Liver Grafts.  Transplantation. Vol. 60, no. 6. (September): 577-584.
  • Bergese SD, Huang EH, Pelletier RP, Widmer MB, Ferguson RM, Orosz CG. 1995. Regulation of Endothelial VCAM-1 Expression in Murine Cardiac Grafts. Expression of Allograft Endothelial VCAM-1 can be Manipulated with Antagonist of IFN-Alpha or IL-4 and is not Required for Allograft Rejection.  Am J Pathol. Vol. 147, no. 1. (April): 166-175.
  • Bergese SD, Pelletier RP, Ferguson RM, Orosz CG. 1995. Graft Endothelial VCAM-1 is not Necessary for Acute Cardiac Allograft Rejection in Mice.  Transplantation Proceedings. Vol. 27, no. 1. (February): 480-481.
  • Bergese SD, Pelletier RP, Vallera DA, Widmer MB, Orosz CG. 1995. Regulation of Endothelial VCAM-1 Expression in Murine Cardiac Grafts. Roles for TNF and IL4.  Am J Pathol. Vol. 4, no. 146. (January): 989-998.
  • Bergese SD, Pelletier RP, Ohye RG, Vallera D, Orosz CG. 1994. Treatment of Mice with Anti-CD3 mAb Induces Endothelial Vascular Cell Adhesion Molecule-1 Expression.  Transplantation. Vol. 57, no. 5. (March): 711-717.
  • Orosz CG, Ohye RG, Pelletier RP, Van Buskirk AM, Huang EH, Morgan CJ, Kincade PW, Ferguson RM. 1993. Treatment with Anti-Vascular Cell Adhesion Molecule 1 Monoclonal Antibody Induces Long-Term Murine Cardiac Allograft Acceptance.  Transplantation. Vol. 56, no. 2. (August): 453-460.
  • Morgan CJ, Pelletier RP, Hernandez CJ, Teske DL, Huang E, Ohye R, Orosz CG, Ferguson RM, Lorber, Miller, Monoco. 1993. Alloantigen-Dependent Endothelial Phenotype and Lymphokine Messenger-RNA Expression in Rejecting Murine Cardiac Allografts. In 18th Annual Meeting of the American Soc of Transplant Surgeons
  • Morgan CJ, Pelletier RP, Hernandex CJ, Teske DL, Huang EH, Ohye RG, Ferguson RM, Orosz CG. 1993. Alloantigen-Dependent Endothelial Phenotype and Lymphokine mRNA Expression in Rejecting Murine Cardiac Allografts.  Transplantation. Vol. 55, no. 4. (April): 919-924.
  • Pelletier RP, Ohye R, Kincade P, Ferguson RM, Orosz CG. 1993. Monoclonal –Antibody to Anti-VCAM-1 Interferes with Murine Cardiac Allograft-Rejection. In Jean Hamburger Memorial Congress/14th International Congress of the Transplantation Society
  • Morgan C, Pelletier RP, Hernandez C, Teske D, Huang E, Ohye R, Ferguson RM, Orosz CG. 1993. Cytokine Messenger-RNA Expression during Development of Acute Rejection in Murine Cardiac Allografts. In Jean Hamburger Memorial Congress/14th International Congress of the Transplant Society
  • Morgan CJ, Pelletier RP, Hernandez CJ, Teske DL, Huang EH, Ohye RG, Ferguson RM. 1993. Cytokine mRNA Expression During Development of Acute Rejection in Murine Cardiac Allografts.  Transplantation Proceedings. Vol. 1, no. 25. (February): 114-116.
  • Pelletier RP, Morgan CJ, Sedmak DD, Kincade PW, Miyake K, Ferguson RM, Orosz CG. 1993. Analysis of Inflammatory Endothelial Changes, Including VCAM-1 Expression, in Murine Cardiac Grafts.  Transplantation. Vol. 55, no. 2. (February): 315-320.
  • Pelletier RP, Ohye RG, Kincade PW, Ferguson RM, Orosz CG. 1993. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. In Transplant Proceedings
  • Pelletier RP, Ohye OG, Kincaide PW, Ferguson RM, Orosz CG. 1993. Monoclonal Antibody to Anti-VCAM-1 Interferes with Murine Cardiac Allograft Rejection.  Transplant Proceedings. Vol. 1, no. 25. (January): 839-841.
  • Morgan CJ, Pelletier RP, Hernandez CJ, Teske DL, Huang EH, Ohye RG Ferguson RM, Orosz CG. 1993. Cytokine mRNA expression during development of acute rejection in murine cardiac allografts. In Transplant Proceedings
  • Pelletier RP, Ohye RG, Vanbuskirk A, Sedmak DD, Kincade P, Ferguson RM, Orosz CG. 1992. Importance of Endothelial VCAM-1 for Inflammatory Leukocytic Infiltration in Vivo.  J. Immunol. Vol. 149, no. 7. (July): 2473-2481.
  • Orosz CG, VanBuskirk A, Sedmak DD, Kincade P, Miyake K, Pelletier RP. 1992. Role of the Endothelial Adhesion Molecule VCAM in Murine Cardiac Allograft Rejection.  Immunology Letters. Vol. 32, no. 1. (March): 7-12.
  • Orosz CG, Pelletier RP, Butcher EC, Miyake K, Kincade PW. 1991. Evidence that Local Antigen Influences Inflammatory Endothelial Phenotype in Vivo.
  • Pelletier RP, Miyake K, Kincade PW, Orosz CG, Ferguson RM. 1991. Inflammation-Induced Expression of the VCAM-1 Adhesion Molecule on Murine Cardiac Endothelium.  Surgical Forum. Vol. na, no. January: 371-373.
  • Galloway AC, Pelletier RP, D'Amore PA. 1984. Do Ischemic Hearts Stimulate Endothelial Cell Growth?.  Surgery. Vol. 2, no. 96. (January): 435-439.
  • Pelletier RP, Henry ML. Program Specific Reports: Friend or Foe? The Intended and Unintended Consequences of Scientific Registry of Transplant Recipient Program Specific Reports.  Clinical Transplantation.
  • Pelletier RP, Phillips GS, Rajab A, Pesavento TE, Henry ML. Effects of Cardiovascular Comorbidity Adjustment on SRTR Risk-Adjusted Cox Proportional Hazard Models of Graft Survival.  Transplantation.
  • Pelletier RP, Bickerstaff AA, Adams PW, Orosz CG. Evaluation of immune regulation in transplant patients using the trans vivo delayed type hypersensitivity assay. Human Immunology 68(6): 514-22, 2007 (Epub, March 28, 2007).
  • Pelletier RP, Soule J, Henry ML, Rajab A, Ferguson RM. Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs. mycophenolate mofetil as a switch agent using a primary steroid-free rapamune and microemulsion cyclosporine protocol. Clinical Transplantation 21(4): 532-5, 2007.
  • Rajab A, Pelletier RP, Ferguson RM, Elkhammas EA, Bumgardner GL, Henry ML. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients. Transplantation 84(9): 1131-7, 2007.

Awards, Honors and Organizations

  • Listed, Best Doctors in America
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000